BMJ:儿童新冠肺炎患者中,年龄越小后遗症风险越高,恢复期更长

2022-01-18 MedSci原创 MedSci原创

挪威儿童及青少年新冠肺炎患者中,学龄前儿童的后遗症风险较高,需要更长的恢复时间,最常见的后遗症为呼吸系统疾病

研究发现,Covid-19成人在首次感染SARS-CoV-2病毒后仍可能会出现3-6个月的症状,主要是呼吸和循环疾病。虽然儿童新冠肺炎患者的比例较低并且多数症状轻微,但仍有后遗症的风险。最新研究发现,新冠肺炎重症患者康复后后遗症及并发症风险较高,而轻症患者可能出现长期后遗症。近日研究人员考察了新冠肺炎儿童患者康复后的后遗症风险以及医疗保健服务需求。


本次研究在挪威开展,2020年8月1日至202年2月1日期间接受SARS-CoV-2检测(阳性病例10279 人次,阴性275859 )或未检测(n=420747)的1-19岁挪威儿童及青少年参与,按年龄进一步分为1-5岁、6-15岁和16-19岁组。研究的主要终点为核酸检测前后6个月,初级保健(全科医生或急诊)和专科保健(门诊或住院患者)的医疗活动。
在SARS-CoV-2检测结果呈阳性后的第一个月内,与检测结果呈阴性的参与者相比,阳性患儿的初级保健使用率在短期内有显著的相对增加(1-5岁:339%;6-15岁:471%;16-19岁:401%)。在两个月(1-5岁:22%;6-15岁:14%;16-19岁:11%)和三个月(1-5岁:26%,6-15岁:15%;16-19岁:11%)时,年龄稍小组儿童的初级保健率仍显著增加。与检测呈阴性的1-5岁儿童相比,阳性儿童在长达6个月内,初级保健率仍相对增加(13%),这一情况在较年长年龄组中没有观察到。对于所有年龄组,初级保健就诊人数的增加是由于呼吸系统不适造成的。没有观察到专科就诊率的显著增加。

新冠肺炎患儿后遗症就诊情况

研究发现,挪威儿童及青少年新冠肺炎患者中,学龄前儿童的后遗症风险较高,需要更长的恢复时间,最常见的后遗症为呼吸系统疾病
原始出处:
Karin Magnusson et al. Healthcare use in 700 000 children and adolescents for six months after covid-19: before and after register based cohort study. BMJ,17 January 2022。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1849363, encodeId=723c18493631c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Jan 21 15:28:41 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1953057, encodeId=ff92195305efc, content=<a href='/topic/show?id=bafc5283ed3' target=_blank style='color:#2F92EE;'>#恢复期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52837, encryptionId=bafc5283ed3, topicName=恢复期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e2c339, createdName=by2009, createdTime=Wed Sep 21 11:28:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418816, encodeId=81e314188163a, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Thu Jan 20 10:28:41 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185798, encodeId=b0e81185e98db, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce506410168, createdName=ms1000001034537119, createdTime=Tue Jan 18 22:23:36 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185765, encodeId=a7cc1185e6517, content=学习到了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11272192802, createdName=pirate, createdTime=Tue Jan 18 21:22:00 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185759, encodeId=360f1185e59af, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Tue Jan 18 21:11:36 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-01-21 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1849363, encodeId=723c18493631c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Jan 21 15:28:41 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1953057, encodeId=ff92195305efc, content=<a href='/topic/show?id=bafc5283ed3' target=_blank style='color:#2F92EE;'>#恢复期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52837, encryptionId=bafc5283ed3, topicName=恢复期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e2c339, createdName=by2009, createdTime=Wed Sep 21 11:28:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418816, encodeId=81e314188163a, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Thu Jan 20 10:28:41 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185798, encodeId=b0e81185e98db, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce506410168, createdName=ms1000001034537119, createdTime=Tue Jan 18 22:23:36 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185765, encodeId=a7cc1185e6517, content=学习到了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11272192802, createdName=pirate, createdTime=Tue Jan 18 21:22:00 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185759, encodeId=360f1185e59af, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Tue Jan 18 21:11:36 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-09-21 by2009
  3. [GetPortalCommentsPageByObjectIdResponse(id=1849363, encodeId=723c18493631c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Jan 21 15:28:41 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1953057, encodeId=ff92195305efc, content=<a href='/topic/show?id=bafc5283ed3' target=_blank style='color:#2F92EE;'>#恢复期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52837, encryptionId=bafc5283ed3, topicName=恢复期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e2c339, createdName=by2009, createdTime=Wed Sep 21 11:28:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418816, encodeId=81e314188163a, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Thu Jan 20 10:28:41 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185798, encodeId=b0e81185e98db, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce506410168, createdName=ms1000001034537119, createdTime=Tue Jan 18 22:23:36 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185765, encodeId=a7cc1185e6517, content=学习到了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11272192802, createdName=pirate, createdTime=Tue Jan 18 21:22:00 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185759, encodeId=360f1185e59af, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Tue Jan 18 21:11:36 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-01-20 huirong
  4. [GetPortalCommentsPageByObjectIdResponse(id=1849363, encodeId=723c18493631c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Jan 21 15:28:41 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1953057, encodeId=ff92195305efc, content=<a href='/topic/show?id=bafc5283ed3' target=_blank style='color:#2F92EE;'>#恢复期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52837, encryptionId=bafc5283ed3, topicName=恢复期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e2c339, createdName=by2009, createdTime=Wed Sep 21 11:28:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418816, encodeId=81e314188163a, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Thu Jan 20 10:28:41 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185798, encodeId=b0e81185e98db, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce506410168, createdName=ms1000001034537119, createdTime=Tue Jan 18 22:23:36 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185765, encodeId=a7cc1185e6517, content=学习到了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11272192802, createdName=pirate, createdTime=Tue Jan 18 21:22:00 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185759, encodeId=360f1185e59af, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Tue Jan 18 21:11:36 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-01-18 ms1000001034537119

    学习啦

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1849363, encodeId=723c18493631c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Jan 21 15:28:41 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1953057, encodeId=ff92195305efc, content=<a href='/topic/show?id=bafc5283ed3' target=_blank style='color:#2F92EE;'>#恢复期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52837, encryptionId=bafc5283ed3, topicName=恢复期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e2c339, createdName=by2009, createdTime=Wed Sep 21 11:28:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418816, encodeId=81e314188163a, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Thu Jan 20 10:28:41 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185798, encodeId=b0e81185e98db, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce506410168, createdName=ms1000001034537119, createdTime=Tue Jan 18 22:23:36 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185765, encodeId=a7cc1185e6517, content=学习到了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11272192802, createdName=pirate, createdTime=Tue Jan 18 21:22:00 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185759, encodeId=360f1185e59af, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Tue Jan 18 21:11:36 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-01-18 pirate

    学习到了新知识

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1849363, encodeId=723c18493631c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Jan 21 15:28:41 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1953057, encodeId=ff92195305efc, content=<a href='/topic/show?id=bafc5283ed3' target=_blank style='color:#2F92EE;'>#恢复期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52837, encryptionId=bafc5283ed3, topicName=恢复期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e2c339, createdName=by2009, createdTime=Wed Sep 21 11:28:41 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418816, encodeId=81e314188163a, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Thu Jan 20 10:28:41 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185798, encodeId=b0e81185e98db, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce506410168, createdName=ms1000001034537119, createdTime=Tue Jan 18 22:23:36 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185765, encodeId=a7cc1185e6517, content=学习到了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11272192802, createdName=pirate, createdTime=Tue Jan 18 21:22:00 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185759, encodeId=360f1185e59af, content=不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Tue Jan 18 21:11:36 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-01-18 仁术2021

    不错,学习了

    0

相关资讯

中药可调节细胞增多症的机制,在多系统疾病中起重要的作用

Efferocytosis 是指吞噬细胞清除凋亡细胞 (AC) 的生理过程。吞噬作用涉及特化吞噬细胞(例如巨噬细胞)和非特化吞噬细胞(例如上皮细胞)。

BMJ:居住环境PM2.5暴露水平变化与心血管和呼吸系统疾病死亡风险密切相关

PM2.5是重要的大气污染物,同时也是造成死亡及致残的重要环境因素,每年全球范围内,约400万人的死亡与较高的PM2.5水平相关。WHO指南认为,年均PM2.5水平在10 μg/m3以上,与居民

呼吸康复的训练方法

呼吸系统疾病康复治疗可促进呼吸道分泌物引流,改善呼吸模式,增加呼吸肌肌力和耐力,减轻紧张和焦虑等心理情绪,最后达到生理功能和心理状态不同程度的恢复。

Thorax:山西省11个城市PM2.5暴露与呼吸系统疾病住院费用和住院天数的关系

山西省呼吸负担可能归因于PM2.5暴露。因此,需要将结果纳入空气污染政策的影响评估,以更完整地表明政策所解决的负担。

Chest:呼吸系统疾病和肺功能低下是痴呆的危险因素

由此可见,肺功能较差的个体患痴呆症的风险增加。尚不清楚肺功能不良与痴呆之间的关联程度如何。

Lancet Respir Med:呼吸系统疾病及其治疗与重度COVID-19的相关性

哮喘患者发生重度COVID-19的风险相对较小。